DRMA·249845504·US·equity·Healthcare - Biotechnology-Activist
DRMA (DERMATA THERAPEUTICS INC) is held by 3 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($58,483), UBS Group AG ($43,085), CITIGROUP INC ($1). Net institutional sentiment: Mixed.
See how DRMA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer